Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 29, 2022

SELL
$8.64 - $11.71 $25,920 - $35,130
-3,000 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$10.95 - $16.07 $10,950 - $16,070
-1,000 Reduced 25.0%
3,000 $32,000
Q3 2021

Oct 18, 2021

BUY
$12.95 - $18.24 $51,800 - $72,960
4,000 New
4,000 $52,000
Q3 2018

Oct 16, 2018

SELL
$2.31 - $4.69 $57,288 - $116,312
-24,800 Closed
0 $0
Q1 2018

Apr 10, 2018

BUY
$3.92 - $5.35 $34,104 - $46,545
8,700 Added 54.04%
24,800 $133,000
Q4 2017

Jan 12, 2018

BUY
$3.9 - $4.66 $9,360 - $11,184
2,400 Added 17.52%
16,100 $63,000
Q3 2017

Oct 13, 2017

BUY
$4.14 - $5.12 $56,717 - $70,144
13,700
13,700 $60,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $173M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.